|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/46 | |
| A61P 35/00 | |||
| C07H 21/04 | |||
| C12N 1/21 | |||
| C12N 15/63 | |||
| C12N 9/82 | |||
| C12P 1/04 |
| (11) | Number of the document | 2046369 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07840229.4 |
| Date of filing the European patent application | 2007-06-08 | |
| (97) | Date of publication of the European application | 2009-04-15 |
| (45) | Date of publication and mention of the grant of the patent | 2015-08-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/070706 |
| Date | 2007-06-08 |
| (87) | Number | WO 2008/011234 |
| Date | 2008-01-24 |
| (30) | Number | Date | Country code |
| 817817 P | 2006-06-30 | US |
| (72) |
FILPULA, David R., US
WANG, Maoliang, US
|
| (73) |
Sigma-Tau Pharma Limited,
21 Holborn Viaduct, London EC1A 2DY,
GB
|
| (54) | RECOMBINANT HOST FOR PRODUCING L-ASPARAGINASE II |
| RECOMBINANT HOST FOR PRODUCING L-ASPARAGINASE II |